Rainbow BioSciences' biotech division Rainbow Coral (RBCC) has revealed that it is currently working on a potential joint venture agreement with a privately held drug delivery company to develop and market a sustained-release drug delivery ...
Tags: RBCC, Sustained-Release Drug, Medicine
Researchers from the Universities of Dundee, Glasgow and Strathclyde have been awarded pound 691,000 as part of the first wave of funding made available through Prostate Cancer UK’s ambitious new research strategy. A colossal pound ...
Tags: Universities of Dundee, Researchers, Prostate Cancer UK
Switching to a diet rich in olive oil, nuts, beans, fish, fruit, vegetables, and even some wine and chocolate can slash your risk of heart attack, stroke, and death from heart disease. That's the conclusion of a landmark study out this week ...
Tags: food safety, medicare, food, medicine
Belgium-based biopharmaceutical company UCB has signed a research deal with ConfometRx for the discovery of new drugs. Under the deal, UCB and ConfometRx will leverage structural biology to gain insight into G-protein coupled receptor ...
Tags: drug discovery, biopharmaceutical, UCB
Ablynx has signed a collaborative agreement with Spirogen to evaluate the potential of a novel anti-cancer drug conjugate. As part of the deal, both the firms will evaluate anti-cancer drug conjugate by using Spirogen's proprietary ...
Tags: Ablynx inks, anti cancer drug, drug
Health Canada has announced the labeling update for all cholesterol-lowering drugs (statins). The update warns about the risk of increased blood sugar levels and an increased risk of diabetes among patients with pre-existing risk factors ...
Germany-based chemical company BASF has signed an agreement with Bend Research to jointly evaluate and develop novel excipients to improve the solubility and bioavailability of poorly soluble drugs. As part of the agreement, both the ...
Tags: soluble drugs, drug formulations, pharmaceutical industry
Take a walk through a human brain? Fly over the surface of Mars? Computer scientists at the University of Illinois at Chicago are pushing science fiction closer to reality with a wraparound virtual world where a researcher wearing 3-D ...
Tags: Computer scientists, computer, system
Neurim Pharmaceuticals has announced positive results from a phase II clinical study reviewing the efficacy and safety of piromelatine. The novel investigational multimodal sleep medicine has been developed for the treatment of patients ...
Tags: Neurim Pharmaceuticals, positive results, phase II clinical study
SCHOTT AG has experienced a strong demand for laboratory services related to so-called “extractables and leachables” (“E&L”) and therefore continued to expand this range of analyses offered to its customers. On the ...
Tags: SCHOTT AG, laboratory services, E&L
The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets. Pioglitazone Tablets USP 15mg, 30mg & 45mg and ...
Tags: USFDA, Aurobindo Pharma, diabetes drugs
Researchers at the National Institutes of Health (NIH) have begun enrolling volunteers for clinical trials to find effective treatments for influenza. One of the studies will assess if treatment with the influenza drug oseltamivir reduces ...
Leading oncology company Incanthera has launched a partnership with global investment group Technomark Life Sciences. The two businesses will work together to prepare ICT2588 - Incanthera’s revolutionary treatment for solid tumours ...
Tags: Life Sciences, clinical trials, medical
Hyglos has announced the commercial launch of EndoZyme®, a homogeneous fluorescence microplate assay using recombinant Factor C derived from horseshoe crab, for measuring endotoxin (Lipopolysaccharides, LPS) in pharmaceuticals, ...
Tags: Endotoxin Detection, Hyglos, medical devices
Pharmaceutical and biotech companies are outsourcing research in order to develop innovative products that meet the rising demand for therapeutics across a range of diseases. The willingness of contract research organisations (CROs) to ...
Tags: Pharmaceutical, CROs, innovative products